Arcadia Biosciences (RKDA) Revenue (2014 - 2025)

Arcadia Biosciences has reported Revenue for 12 years, with the latest figure at $901000.0 in Q4 2025.

• For the quarter ending Q4 2025, Revenue fell 25.9% year-over-year to $901000.0; the trailing twelve-month figure through Dec 2025 stood at $4.9 million (down 3.73% YoY), and the FY2025 full-year result was $4.9 million, down 3.71% from the prior year.
• Revenue for Q4 2025 stood at $901000.0, down from $1.3 million in the prior quarter.
• The five-year high for Revenue was $837.0 million in Q2 2021, with the low at -$5.8 million in Q4 2022.
• Historically, Revenue has averaged $43.1 million across 5 years, with a median of $1.3 million in 2023.
• Annual changes were most pronounced in 2021 — Revenue surged 297764.77% — and 2022, when it slumped 235.16%.
• Arcadia Biosciences' Revenue stood at $4.3 million in 2021, then tumbled by 235.16% to -$5.8 million in 2022, then jumped by 113.37% to $777000.0 in 2023, then jumped by 56.5% to $1.2 million in 2024, then declined by 25.9% to $901000.0 in 2025.
• The last three Revenue figures came in at $901000.0 (Q4 2025), $1.3 million (Q3 2025), and $1.5 million (Q2 2025), per Business Quant data.